Brokerages Issued Hannover Re (HNR1) Target Price at $114.83

Brokerages Issued Hannover Re (HNR1) Target Price at $114.83

Hannover Re (FRA:HNR1) has been given an average recommendation of “Hold” by the twenty brokerages that are presently covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a sell rating and sixteen have assigned a hold rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is €115.28 ($134.04).

A number of research analysts have recently commented on HNR1 shares. UBS Group set a €115.00 ($133.72) price objective on shares of Hannover Re and gave the company a “neutral” rating in a research report on Tuesday, October 16th. DZ Bank reaffirmed a “neutral” rating on shares of Hannover Re in a research report on Friday, October 19th. equinet set a €110.00 ($127.91) price objective on shares of Hannover Re and gave the company a “neutral” rating in a research report on Friday, October 19th. Barclays set a €105.20 ($122.33) price objective on shares of Hannover Re and gave the company a “sell” rating in a research report on Friday, October 19th. Finally, Goldman Sachs Group set a €116.00 ($134.88) price objective on shares of Hannover Re and gave the company a “neutral” rating in a research report on Monday, October 22nd.

Shares of HNR1 traded down €0.70 ($0.81) during trading hours on Wednesday, reaching €125.80 ($146.28). 178,268 shares of the company traded hands. Hannover Re has a 1-year low of €94.75 ($110.17) and a 1-year high of €116.37 ($135.31).

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

Recommended Story: NASDAQ

Related posts

Leave a Comment